Dubai: The Centre for Arab Genomic Studies (CAGS) conducted the second webinar in its monthly webinar series.  Yesterday’s program focused on Population Genetics, and was attended by more than 600 participants from all over the world.

The webinar started with a short remembrance speech about the Late Sheikh Hamdan bin Rashid Al Maktoum, the Patron of the Hamdan Medical Award, who passed away last wednesday March 24th, 2021.  In her speech, Dr. Stephany El- Hayek, Assistant Director of CAGS, emphasized that the late Sheikh Hamdan was a true visionary who dedicated a large part of his time and efforts towards improving the state of healthcare here in the UAE and also around the world.

“It was actually his vision of reducing the burden of genetic disorders in the Arab World that led to the establishment of our Centre. His passing is a big loss for us at CAGS and the Award, and also for the wider medical and humanitarian community. We truly hope that we can continue our work on the path guided by Sheikh Hamdan’s vision”, she said.

 His Excellency Abdullah Bin Souqat, Executive Director of the Award, highlighted  the richness of the webinar topic and praised the efforts of the CAGS and the Award team. He also stressed that the Centre's organization of this webinar aims to enhance communication between specialists even during the Covid-19 pandemic.

The webinar hosted talks by Dr. Pierre Zalloua, Professor of Genetics at the Khalifa University, Abu Dhabi and Dr. David Comas, Head of the Human Genome Diversity Group at the Universitat Pompeu Fabra (UPF) in Barcelona. The program was moderated by Dr. Riad Bayoumi, MBRU, UAE.

The webinar series had been launched by CAGS in February with a webinar that discussed the “Genomics of Infectious Diseases”, with more than 400 participants from all over the world. The next webinar in this series, on “Gene Therapy”, will be held on May 26th.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.